Panchabhai, S
Kelemen, K
Ahmann, G
Sebastian, S
Mantei, J
Fonseca, R
Article History
First Online: 23 July 2015
Competing interests
: FR has sponsored research from AMGEN, Celgene, Onyx and Sanofi. He has received consulting fees from Bayer, Novartis, Onyx, Pharmacyclics, Sanofi and serves on the advisory committee of Applied Biosciences. He has received a patent for the prognostication of MM based on genetic categorization of the disease The remaining authors declare no competing financial interests.